Brown Justin C, Allicock Marlyn, Valle Carmina G, Agurs-Collins Tanya
Pennington Biomedical Research Center Baton Rouge Louisiana USA.
LSU Health Sciences Center New Orleans School of Medicine New Orleans Louisiana USA.
Obes Sci Pract. 2024 Nov 29;10(6):e70027. doi: 10.1002/osp4.70027. eCollection 2024 Dec.
Obesity is a chronic, relapsing, progressive disease of excess adiposity that increases the risk of dying from at least 16 types of cancer. The prevalence of obesity has increased more rapidly in cancer survivors compared with the general population. Tailored weight management strategies are needed to improve prognosis and health outcomes in the growing population of cancer survivors. However, certain cancer survivor population subgroups require unique consideration when developing weight management strategies.
In a symposium convened by The Obesity Society during ObesityWeek 2023 titled "From Surviving to Thriving: Key Considerations for Weight Control Across Diverse Cancer Survivorship Populations," experts presented the current state of the science and highlighted existing research gaps.
Topics included key considerations for weight management in adolescent and young adult cancer survivors, older adult cancer survivors, and understudied cancer survivor subgroups at high risk for poor health outcomes and innovative interventions that can be tested to improve cancer survivorship.
This report reviews the symposium and offers perspectives from the expert panel about unique opportunities for future research on tailored weight management strategies to equitably improve prognosis and health outcomes in the diverse and growing population of cancer survivors.
肥胖是一种慢性、复发性、进行性的脂肪过多疾病,会增加至少16种癌症的死亡风险。与普通人群相比,癌症幸存者中的肥胖患病率增长更为迅速。需要制定量身定制的体重管理策略,以改善不断增加的癌症幸存者群体的预后和健康结局。然而,在制定体重管理策略时,某些癌症幸存者亚群体需要特别考虑。
在肥胖协会于2023年肥胖周期间召开的题为“从生存到繁荣:不同癌症幸存者群体体重控制的关键考虑因素”的研讨会上,专家们介绍了当前的科学现状,并强调了现有的研究差距。
主题包括青少年和青年癌症幸存者、老年癌症幸存者以及健康结局较差风险较高且尚未充分研究的癌症幸存者亚群体体重管理的关键考虑因素,以及可进行测试以改善癌症生存情况的创新干预措施。
本报告回顾了该研讨会,并提供了专家小组对于未来研究量身定制的体重管理策略的独特机会的观点,以便在多样化且不断增长的癌症幸存者群体中公平地改善预后和健康结局。